37 related articles for article (PubMed ID: 32087464)
1. Pentathiepins: A Novel Class of Glutathione Peroxidase 1 Inhibitors that Induce Oxidative Stress, Loss of Mitochondrial Membrane Potential and Apoptosis in Human Cancer Cells.
Behnisch-Cornwell S; Bandaru SSM; Napierkowski M; Wolff L; Zubair M; Urbainsky C; Lillig C; Schulzke C; Bednarski PJ
ChemMedChem; 2020 Aug; 15(16):1515-1528. PubMed ID: 32311219
[TBL] [Abstract][Full Text] [Related]
2. Exploration of 3,4-unsubstituted coumarins as thioredoxin reductase 1 inhibitors for cancer therapy.
Nikitjuka A; Ozola M; Jackevica L; Bobrovs R; Žalubovskis R
Org Biomol Chem; 2023 Dec; 21(48):9630-9639. PubMed ID: 38018884
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.
Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A
Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347
[TBL] [Abstract][Full Text] [Related]
4. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Bioactivity Evaluations of 3-Methylenechroman-2-one Derivatives as Thioredoxin Reductase (TrxR) Inhibitors.
Nikitjuka A; Ozola M; Krims-Davis K; Žalubovskis R
ChemMedChem; 2024 Feb; 19(3):e202300504. PubMed ID: 38063319
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new tricyclic spiroindole derivatives as potent P-glycoprotein inhibitors for reversing multidrug resistance enabled by a synthetic methodology-based library.
Yu T; Zeng R; Guan Y; Pan B; Li HW; Gu J; Zheng PF; Qian Y; Ouyang Q
RSC Med Chem; 2024 May; 15(5):1675-1685. PubMed ID: 38784466
[TBL] [Abstract][Full Text] [Related]
7. May 1,2-Dithiolane-4-carboxylic Acid and Its Derivatives Serve as a Specific Thioredoxin Reductase 1 Inhibitor?
Nikitjuka A; Krims-Davis K; Kaņepe-Lapsa I; Ozola M; Žalubovskis R
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764424
[TBL] [Abstract][Full Text] [Related]
8. Oxidative Stress Linking Obesity and Cancer: Is Obesity a 'Radical Trigger' to Cancer?
Jovanović M; Kovačević S; Brkljačić J; Djordjevic A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176160
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR.
Hu J; Chen L; Lu Z; Yao H; Hu Y; Feng L; Pang Y; Wu JQ; Yu Z; Chen WH
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770971
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance.
Jovanović M; Podolski-Renić A; Krasavin M; Pešić M
Front Mol Biosci; 2022; 9():883297. PubMed ID: 35664671
[TBL] [Abstract][Full Text] [Related]
11. Onopordopicrin from the new genus
Zhang J; Zheng ZQ; Xu Q; Li Y; Gao K; Fang J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):790-801. PubMed ID: 33733960
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-dependent system. Application of inhibitors.
Jastrząb A; Skrzydlewska E
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):362-371. PubMed ID: 33356659
[TBL] [Abstract][Full Text] [Related]
13. Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy.
Jovanović M; Dragoj M; Zhukovsky D; Dar'in D; Krasavin M; Pešić M; Podolski-Renić A
Front Mol Biosci; 2020; 7():586146. PubMed ID: 33134322
[TBL] [Abstract][Full Text] [Related]
14. Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential.
Jovanović M; Zhukovsky D; Podolski-Renić A; Žalubovskis R; Dar'in D; Sharoyko V; Tennikova T; Pešić M; Krasavin M
Eur J Med Chem; 2020 Apr; 191():112119. PubMed ID: 32087464
[TBL] [Abstract][Full Text] [Related]
15. Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.
Jovanović M; Zhukovsky D; Podolski-Renić A; Domračeva I; Žalubovskis R; Senćanski M; Glišić S; Sharoyko V; Tennikova T; Dar'in D; Pešić M; Krasavin M
Eur J Med Chem; 2019 Nov; 181():111580. PubMed ID: 31400708
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
[TBL] [Abstract][Full Text] [Related]
17. Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines.
Liao J; Wang L; Wu Z; Wang Z; Chen J; Zhong Y; Jiang F; Lu Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1158-1163. PubMed ID: 31179772
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
